MIR338 Gene

HGNC Family Non-coding RNAs
Name microRNA 338
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe microRNA‐338 family—including miR‑338‑3p and miR‑338‑5p—has emerged as a multifaceted regulator in cancer. In numerous solid tumors such as colorectal, gastric, esophageal, hepatocellular, non‑small cell lung, breast, prostate, oral, nasopharyngeal cancers, and neuroblastoma, miR‑338 is frequently downregulated. This loss promotes oncogenic behaviors by relieving its normally inhibitory influence on multiple targets (for example, PREX2a, P‑Rex2a, NRP1, FOXP4, CyclinD1, MACC1, RAB14, PTP1B, TAZ, and key mediators of hypoxic and inflammatory feedback loops such as HIF‑1α and IL‑6). Consequently, reduced miR‑338 expression contributes to increased cell proliferation, migration, invasion, epithelial–mesenchymal transition, angiogenesis, chemoresistance, and radioresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond oncology, miR‑338 plays important roles in non‑neoplastic contexts. It is involved in neuronal differentiation and synaptic regulation—as illustrated by its co‑transcription from the intron of the apoptosis‑associated tyrosine kinase gene—and its dysregulation has been linked to neurodegenerative and neuropsychiatric disorders such as amyotrophic lateral sclerosis, Alzheimer’s disease, and the 22q11.2 deletion syndrome associated with schizophrenia. In addition, altered circulating levels of miR‑338 have been observed in disorders affecting bone and vascular health—including postmenopausal osteoporosis, deep venous thrombosis, and asthma‑COPD overlap syndrome—highlighting its promise as a diagnostic biomarker in diverse settings."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "31", "end_ref": "40"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurthermore, the regulatory network governing miR‑338 expression is itself complex. Multiple long non‑coding and circular RNAs—including circ_0001649, CRNDE, SNHG15, OIP5‑AS1, and exosome‑derived circRNAs—act as competing endogenous RNAs to modulate miR‑338 availability. In parallel, transcription factors such as HIF‑1α and hormonal regulators fine‑tune its expression under stress conditions such as hypoxia, thereby impacting downstream pathways controlling metabolism, autophagy, and adaptive responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}, {"type": "fg_f", "ref": "41"}, {"type": "fg_f", "ref": "30"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Miao Yang, Ran Liu, Jingyi Sheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2012.2105"}], "href": "https://doi.org/10.3892/or.2012.2105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23124769"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23124769"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Kai Sun, Hai-Jun Deng, Shang-Tong Lei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Gastroenterol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3748/wjg.v19.i14.2197"}], "href": "https://doi.org/10.3748/wjg.v19.i14.2197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23599646"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23599646"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Fung Lin Yong, Chee Wei Law, Chee Woon Wang "}, {"type": "b", "children": [{"type": "t", "text": "Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-13-280"}], "href": "https://doi.org/10.1186/1471-2407-13-280"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23758639"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23758639"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Xin Chen, Min Pan, Lulu Han, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2013.09.044"}], "href": "https://doi.org/10.1016/j.febslet.2013.09.044"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24140344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24140344"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Bo Guo, Liying Liu, Jiayi Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer Res (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1541-7786.MCR-13-0507"}], "href": "https://doi.org/10.1158/1541-7786.MCR-13-0507"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24375644"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24375644"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Yang Peng, Yan-Min Liu, Lu-Chun Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0094422"}], "href": "https://doi.org/10.1371/journal.pone.0094422"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24736504"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24736504"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Chunxi Liu, Zhiyu Wang, Yi Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338 suppresses the growth and metastasis of OSCC cells by targeting NRP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biochem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11010-014-2211-3"}], "href": "https://doi.org/10.1007/s11010-014-2211-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25204970"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25204970"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Gang Wang, Yubei Sun, Yifu He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25755720"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25755720"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Na Huang, Zhenzhen Wu, Li Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.3835"}], "href": "https://doi.org/10.18632/oncotarget.3835"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25945841"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25945841"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Huizhen Nie, Jun Li, Xiao-Mei Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.27940"}], "href": "https://doi.org/10.1002/hep.27940"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26082033"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26082033"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Ying Shan, Xingyu Li, Bo You, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncol Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/or.2015.4195"}], "href": "https://doi.org/10.3892/or.2015.4195"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26260688"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26260688"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Peng Liu, Hualin Zhang, Xiaohong Liang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4804"}], "href": "https://doi.org/10.18632/oncotarget.4804"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26315112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26315112"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jiang-Tao Chen, Kun-Hou Yao, Long Hua, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-3p inhibits the proliferation and migration of gastric cancer cells by targeting ADAM17."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Exp Pathol (2015)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26617808"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26617808"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Andrej Besse, Jiri Sana, Radek Lakomy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4654-x"}], "href": "https://doi.org/10.1007/s13277-015-4654-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26692101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26692101"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Deqiang Lei, Fangcheng Zhang, Dongxiao Yao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2017.01.137"}], "href": "https://doi.org/10.1016/j.biopha.2017.01.137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28292024"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28292024"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yingchun Liang, Xiaojie Xu, Tao Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cddis.2017.325"}], "href": "https://doi.org/10.1038/cddis.2017.325"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28703807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28703807"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Misun Park, Hyeon-Joon Yoon, Moon Chul Kang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-5p enhances the radiosensitivity of esophageal squamous cell carcinoma by inducing apoptosis through targeting survivin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-017-10977-9"}], "href": "https://doi.org/10.1038/s41598-017-10977-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28883406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28883406"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jia Han, Jie Li, Kaijie Tang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-3p confers 5-fluorouracil resistance in p53 mutant colon cancer cells by targeting the mammalian target of rapamycin."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Cell Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexcr.2017.09.023"}], "href": "https://doi.org/10.1016/j.yexcr.2017.09.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28928082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28928082"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "F-F Hua, S-S Liu, L-H Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201712_13919"}], "href": "https://doi.org/10.26355/eurrev_201712_13919"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29243777"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29243777"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Feng Sun, Mengchao Yu, Jing Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-3p functions as a tumor suppressor in gastric cancer by targeting PTP1B."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-018-0611-0"}], "href": "https://doi.org/10.1038/s41419-018-0611-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29743567"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29743567"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Tongmiao Liu, Zhuo Song, Yanling Gai "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA circ_0001649 acts as a prognostic biomarker and inhibits NSCLC progression via sponging miR-331-3p and miR-338-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2018.07.070"}], "href": "https://doi.org/10.1016/j.bbrc.2018.07.070"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30029881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30029881"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Hongyu Jing, Huan Xia, Ming Qian, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA CRNDE promotes non-small cell lung cancer progression via sponging microRNA-338-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2018.12.024"}], "href": "https://doi.org/10.1016/j.biopha.2018.12.024"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30554121"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30554121"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Wen-Chun Lin, Li-Han Chen, Yao-Chin Hsieh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-5p inhibits cell proliferation, colony formation, migration and cisplatin resistance in esophageal squamous cancer cells by targeting FERMT2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgy189"}], "href": "https://doi.org/10.1093/carcin/bgy189"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30576425"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30576425"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Min Li, Zehua Bian, Guoying Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cam4.2105"}], "href": "https://doi.org/10.1002/cam4.2105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30945457"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30945457"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Yuelong Zhang, Dahong Zhang, Jia Lv, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2019.04.033"}], "href": "https://doi.org/10.1016/j.gene.2019.04.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30981837"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30981837"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Chien-An Chu, Chung-Ta Lee, Jenq-Chang Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-338-5p promotes metastasis of colorectal cancer by inhibition of phosphatidylinositol 3-kinase, catalytic subunit type 3-mediated autophagy pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2019.04.010"}], "href": "https://doi.org/10.1016/j.ebiom.2019.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30982765"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30982765"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Yuzhu Xu, Jun Yu, Zhenli Huang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Clin Cancer Res (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13046-020-01556-4"}], "href": "https://doi.org/10.1186/s13046-020-01556-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32248836"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32248836"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Juanjuan He, Jing Wang, Songchao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cas.14589"}], "href": "https://doi.org/10.1111/cas.14589"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32726486"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32726486"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Sepideh Mirzaei, Ali Zarrabi, Sholeh Etehad Asnaf, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.119005"}], "href": "https://doi.org/10.1016/j.lfs.2020.119005"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33421526"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33421526"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Xihao Yao, Yingqing Mao, Di Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomal circ_0030167 derived from BM-MSCs inhibits the invasion, migration, proliferation and stemness of pancreatic cancer cells by sponging miR-338-5p and targeting the Wif1/Wnt8/β-catenin axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Lett (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.canlet.2021.04.030"}], "href": "https://doi.org/10.1016/j.canlet.2021.04.030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33971282"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33971282"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Sailen Barik "}, {"type": "b", "children": [{"type": "t", "text": "An intronic microRNA silences genes that are functionally antagonistic to its host gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nucleic Acids Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/nar/gkn513"}], "href": "https://doi.org/10.1093/nar/gkn513"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18684991"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18684991"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Marco Ragusa, Alessandra Majorana, Barbara Banelli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Mol Med (Berl) (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00109-010-0643-0"}], "href": "https://doi.org/10.1007/s00109-010-0643-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20574809"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20574809"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Bruna De Felice, Marco Guida, Maurizio Guida, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A miRNA signature in leukocytes from sporadic amyotrophic lateral sclerosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2012.07.058"}], "href": "https://doi.org/10.1016/j.gene.2012.07.058"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22903028"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22903028"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Bruna De Felice, Anna Annunziata, Giuseppe Fiorentino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurogenetics (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10048-014-0420-2"}], "href": "https://doi.org/10.1007/s10048-014-0420-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25130371"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25130371"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Sungkun Chun, Fei Du, Joby J Westmoreland, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.4240"}], "href": "https://doi.org/10.1038/nm.4240"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27892953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27892953"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Donato Lacedonia, Grazia Pia Palladino, Maria Pia Foschino-Barbaro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Chron Obstruct Pulmon Dis (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2147/COPD.S130616"}], "href": "https://doi.org/10.2147/COPD.S130616"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28694694"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28694694"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Yu Hou, Wenquan Liang, Jian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Schizophr Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.schres.2018.02.040"}], "href": "https://doi.org/10.1016/j.schres.2018.02.040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29499969"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29499969"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Qi Qian, Jian Zhang, Fang-Ping He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FASEB J (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1096/fj.201801846R"}], "href": "https://doi.org/10.1096/fj.201801846R"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30576233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30576233"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Chujiao Lin, Shuaitong Yu, Runze Jin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Theranostics (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/thno.34493"}], "href": "https://doi.org/10.7150/thno.34493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31281513"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31281513"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Yunhong Zhang, Zhen Zhang, Ran Wei, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IL (Interleukin)-6 Contributes to Deep Vein Thrombosis and Is Negatively Regulated by miR-338-5p."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arterioscler Thromb Vasc Biol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/ATVBAHA.119.313137"}], "href": "https://doi.org/10.1161/ATVBAHA.119.313137"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31852218"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31852218"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "Xin Liu, Qiaojuan Zhu, Yang Guo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109069"}], "href": "https://doi.org/10.1016/j.biopha.2019.109069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31181442"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31181442"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Minghe Li, Jun Ning, Zhihong Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA OIP5-AS1 promotes the progression of oral squamous cell carcinoma via regulating miR-338-3p/NRP1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biomed Pharmacother (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.biopha.2019.109259"}], "href": "https://doi.org/10.1016/j.biopha.2019.109259"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31369989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31369989"}]}]}]}
Synonyms HSA-MIR-338, MIRN338, MIR-338
NCBI Gene ID 442906
API
Download Associations
Predicted Functions View MIR338's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR338's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR338's ARCHS4 Predicted Functions.

Functional Associations

MIR338 has 467 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 17 datasets.

Click the + buttons to view associations for MIR338 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR338 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR338 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR338 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR338 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR338 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR338 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR338 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR338 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR338 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR338 from the GeneSigDB Published Gene Signatures dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR338 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR338 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR338 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR338 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR338 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of MIR338 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR338 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.